Astrid Berger

Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk <i>In vivo</i>

Nicole Concin, Gerda Hofstetter, Astrid Berger et al. · Clinical Cancer Research · 2005 · 88 citations

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

Gerda Hofstetter, Astrid Berger, Heidi Fiegl et al. · Oncogene · 2010 · 79 citations

Independent Prognostic Marker, Medicine, Pathology +9

Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study

Tamara Stampalija, Jim Thornton, Neil Marlow et al. · Ultrasound in Obstetrics and Gynecology · 2020 · 77 citations · Full text

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium

Dietmar Pils, Anna Bachmayr-Heyda, Katharina Auer et al. · European Journal of Cancer · 2013 · 65 citations

Prognostic Biomarkers, Ovcad Consortium, Medicine +8

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Gerda Hofstetter, Astrid Berger, E. Schuster et al. · British Journal of Cancer · 2011 · 47 citations · Full text